These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36801514)

  • 1. Characteristics and clinical correlates of risk symptoms in individuals at clinical high-risk for psychosis: A systematic review and meta-analysis.
    Cooper SM; Fusar-Poli P; Uhlhaas PJ
    Schizophr Res; 2023 Apr; 254():54-61. PubMed ID: 36801514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
    Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
    Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probability of Transition to Psychosis in Individuals at Clinical High Risk: An Updated Meta-analysis.
    Salazar de Pablo G; Radua J; Pereira J; Bonoldi I; Arienti V; Besana F; Soardo L; Cabras A; Fortea L; Catalan A; Vaquerizo-Serrano J; Coronelli F; Kaur S; Da Silva J; Shin JI; Solmi M; Brondino N; Politi P; McGuire P; Fusar-Poli P
    JAMA Psychiatry; 2021 Sep; 78(9):970-978. PubMed ID: 34259821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment.
    Solmi M; Soardo L; Kaur S; Azis M; Cabras A; Censori M; Fausti L; Besana F; Salazar de Pablo G; Fusar-Poli P
    Mol Psychiatry; 2023 Jun; 28(6):2291-2300. PubMed ID: 37296309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.
    Modinos G; Kempton MJ; Tognin S; Calem M; Porffy L; Antoniades M; Mason A; Azis M; Allen P; Nelson B; McGorry P; Pantelis C; Riecher-Rössler A; Borgwardt S; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Glenthøj B; Ruhrmann S; Sachs G; Rutten B; van Os J; de Haan L; Velthorst E; van der Gaag M; Valmaggia LR; McGuire P;
    JAMA Psychiatry; 2020 Feb; 77(2):190-200. PubMed ID: 31722018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of basic and attenuated-psychotic symptoms in individuals at clinical high risk for psychosis: pattern of symptom onset and effects of duration on functioning and cognition.
    Staines L; Gajwani R; Gross J; Gumley AI; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
    BMC Psychiatry; 2021 Jul; 21(1):339. PubMed ID: 34233651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition to psychosis in randomized clinical trials of individuals at clinical high risk of psychosis compared to observational cohorts: a systematic review and meta-analysis.
    Salazar de Pablo G; Davies C; de Diego H; Solmi M; Shin JI; Carvalho AF; Radua J; Fusar-Poli P
    Eur Psychiatry; 2021 Jul; 64(1):e51. PubMed ID: 34315555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk: A Systematic Review and Meta-Analysis.
    Raballo A; Poletti M; Preti A
    JAMA Psychiatry; 2024 Jul; 81(7):727-730. PubMed ID: 38506802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention.
    Catalan A; Salazar de Pablo G; Vaquerizo Serrano J; Mosillo P; Baldwin H; Fernández-Rivas A; Moreno C; Arango C; Correll CU; Bonoldi I; Fusar-Poli P
    J Child Psychol Psychiatry; 2021 May; 62(5):657-673. PubMed ID: 32924144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis.
    Catalan A; Salazar de Pablo G; Aymerich C; Damiani S; Sordi V; Radua J; Oliver D; McGuire P; Giuliano AJ; Stone WS; Fusar-Poli P
    JAMA Psychiatry; 2021 Jun; 78(8):859-67. PubMed ID: 34132736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis.
    Oliver D; Arribas M; Radua J; Salazar de Pablo G; De Micheli A; Spada G; Mensi MM; Kotlicka-Antczak M; Borgatti R; Solmi M; Shin JI; Woods SW; Addington J; McGuire P; Fusar-Poli P
    Mol Psychiatry; 2022 Sep; 27(9):3670-3678. PubMed ID: 35665763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis.
    Salazar de Pablo G; Besana F; Arienti V; Catalan A; Vaquerizo-Serrano J; Cabras A; Pereira J; Soardo L; Coronelli F; Kaur S; da Silva J; Oliver D; Petros N; Moreno C; Gonzalez-Pinto A; Díaz-Caneja CM; Shin JI; Politi P; Solmi M; Borgatti R; Mensi MM; Arango C; Correll CU; McGuire P; Fusar-Poli P
    EClinicalMedicine; 2021 Jun; 36():100909. PubMed ID: 34189444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
    Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
    Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
    Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
    JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.
    Fusar-Poli P; Salazar de Pablo G; Correll CU; Meyer-Lindenberg A; Millan MJ; Borgwardt S; Galderisi S; Bechdolf A; Pfennig A; Kessing LV; van Amelsvoort T; Nieman DH; Domschke K; Krebs MO; Koutsouleris N; McGuire P; Do KQ; Arango C
    JAMA Psychiatry; 2020 Jul; 77(7):755-765. PubMed ID: 32159746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the variability of neurocognitive functioning in individuals at clinical high risk for psychosis: a meta-analysis.
    Catalan A; Radua J; McCutcheon R; Aymerich C; Pedruzo B; González-Torres MÁ; Baldwin H; Stone WS; Giuliano AJ; McGuire P; Fusar-Poli P
    Transl Psychiatry; 2022 May; 12(1):198. PubMed ID: 35551176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of tobacco smoking in people at clinical high-risk for psychosis: Systematic review and meta-analysis.
    De Micheli A; Provenzani U; Solmi M; Van Pabst AVL; Youssef E; McGuire P; Fusar-Poli P
    Schizophr Res; 2023 Apr; 254():109-115. PubMed ID: 36827942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline antipsychotic prescription and short-term outcome indicators in individuals at clinical high-risk for psychosis: Findings from the Parma At-Risk Mental States (PARMS) program.
    Pelizza L; Leuci E; Quattrone E; Azzali S; Paulillo G; Pupo S; Poletti M; Raballo A; Pellegrini P; Menchetti M
    Early Interv Psychiatry; 2024 Feb; 18(2):71-81. PubMed ID: 37194411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions and social functioning in youth at risk of psychosis: A systematic review and meta-analysis.
    Devoe DJ; Farris MS; Townes P; Addington J
    Early Interv Psychiatry; 2019 Apr; 13(2):169-180. PubMed ID: 29938910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.